Screener
TransCode Therapeutics, Inc. RNAZ Q1 2025 Annual earnings
Reported May 14, 2025 · Before market open
EPS-$16.81Miss by $13.60
Revenue estimate$300.0K
EPS estimate-$3.21
Next report
Aug 18, 2026 (In 6 days)Versus estimates
Diluted EPS
FAQ
- When did TransCode Therapeutics, Inc. report Q1 2025 earnings?
- TransCode Therapeutics, Inc. (RNAZ) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were TransCode Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- TransCode Therapeutics, Inc. reported eps of $-16.81 for Q1 2025.
- Did TransCode Therapeutics, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-3.21 by $13.60.
- How did TransCode Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 21.6% from $-21.45.
- Where can I find TransCode Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001558370-25-004843) directly on SEC EDGAR. The filing index links above go to sec.gov.
